RE: Sir Patrick Vallance £600k share holding in Firm contracted to develop VACCINES24 Sep 2020 09:36
I'm not suggesting that the article was rich in research or insight but as I said at the time, the motley fool's target audience is newbie investors looking for long term holds. It's prudent to warn them off what might seem 'get rich quick' schemes and without doubt investing in synairgen at £2 requires a much higher risk tolerance than their usual 'tips' such as Aviva, national express, GSK etc etc.
I just didn't think it was helpful to completely disregard the articles and write them off as some sort of conspiracy.